Home Tags Health research
Health research Related Content
Professor Hannah Wexler discusses her work with Bacteroides fragilis, an important commensal in the gut microbiome but also the most important clinical anaerobic pathogen.
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
The funding will be used to deliver four new projects as part of the Global AMR Innovation Fund (GAMRIF)
According to the recent CIPD survey, people coming into work when they are ill also known as ‘presenteeism’ has more than tripled since 2010, with 86% of employees admitting they had observed presenteeism in the workplace
NIH-funded study closes in on personalised drug testing for neurological disorders
Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations
Open Access Government details the work of the National Toxicology Program, a world leader in providing scientific information to help evaluate and better understand the potential health effects of exposure to chemicals and other substances
Researchers from the University of Oxford and Novo Nordisk are collaborating to develop better treatments for type 2 diabetes
Today, The Aplastic Anaemia Trust (AAT) launches their new research strategy, inviting prospective applicants to come forward with proposals for truly translational research into aplastic anaemia (AA), as CEO Grazina Berry reveals
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
Endocrine Disrupting Chemicals (EDC) are chemical substances that can damage our health and/or the health of environmental organisms by altering the hormone function.
CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
Dr Dimiter Prodanov from IMEC vzw shares his views on the fascinating world of nanomaterials including the governance of nano-related risk
The University Clinic of Nuclear Medicine conducts examinations and treatments on patients with radioactive drugs. This includes radiation protection with its medical, physical and biological fundamentals
SMA Europe e.V. discusses how new treatments for spinal muscular atrophy open up new challenges for European and national institutions
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
Jon Snaedal, professor in Geriatric Medicine, Landspitali University Hospital in Reykjavik, Iceland shares his expertise on dementia research including the early diagnosis of brain disorders
The work of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, including muscular dystrophy (MD), is placed under the spotlight by Open Access Government
Researchers at the National Institutes of Health (NIH) have used genomics to set apart squamous cancer cells (SCC’s) from other cancers. This could improve treatments for head and neck cancers.